PACB
Ticker
Pacific Biosciences of Californ
Company
LifeSciences
Industry
Healthcare
Sector
Financial Ratio Analysis
2009
+
2010
+
2011
+
2012
+
2013
+
2014
+
2015
+
2016
+
2017
+
2018
+
2019
+
2020
+
2021
+
2022
+
2023
+
2024
+
2025
TTM
Revenue Growth YoY
β€”1140.0%1922.9%-23.3%8.5%115.0%53.1%-2.2%3.0%-15.9%15.6%-13.2%65.4%-1.7%56.3%-23.2%β€”-10.7%
Revenue Growth QoQ
β€”1140.0%1922.9%-23.3%8.5%115.0%53.1%-2.2%3.0%-15.9%15.6%-13.2%65.4%-1.7%56.3%-23.2%β€”β€”
Gross Margin
100.0%100.0%38.5%3.6%22.8%38.6%57.6%48.7%37.1%31.9%38.0%41.3%45.1%38.2%26.3%24.2%β€”25.4%
EBITDA Margin
-62197.0%-8068.9%-307.0%-337.5%-255.1%-96.8%-27.4%-74.3%-87.0%-119.3%-102.6%-124.2%-155.4%-231.3%-157.0%-281.2%β€”-179.4%
Operating Margin
-65237.0%-8377.2%-324.1%-363.1%-275.2%-103.7%-31.4%-78.5%-96.1%-128.4%-110.6%-132.3%-161.2%-239.4%-166.8%-308.0%β€”-430.6%
Profit Margin
-64965.2%-8373.1%-323.0%-363.6%-281.4%-109.2%-34.2%-82.0%-98.6%-130.4%-92.6%37.3%-138.9%-244.9%-153.0%-201.2%β€”-325.8%
FCF / EBITDA
95.3%94.2%108.0%89.5%42.8%90.5%199.9%113.0%95.8%72.8%87.0%-18.8%57.7%94.4%85.2%49.0%β€”47.3%